Nuclear Medicine and Biology
Volume 33, Issue 3 , Pages 367-370 , April 2006

Synthesis of 5-radioiodoarabinosyl uridine analog for probing HSV-1 thymidine kinase gene: an unexpected chelating effect

Received 2 June 2005 ,Revised 8 December 2005 ,Accepted 8 December 2005.

References 

  1. Peñuelas I, Boán JF, Martý-Climent JM, Sangro B, Mazzolini G, Prieto J, et al. Positron emission tomography and gene therapy: basic concepts and experimental approaches for in vivo gene expression imaging. Mol Imaging Biol. 2004;6:225–238
  2. Herschman HR. PET reporter genes for noninvasive imaging of gene therapy, cell tracking and transgenic analysis. Crit Rev Oncol Hemat. 2004;51:91–204
  3. de Vries EFJ, Buursma AR, Hospers GAP, Mulder NH, Vaalburg W. Scintigraphic imaging of HSVtk gene therapy. Curr Pharm Des. 2002;8:1435–1450
  4. Nichol C, Kim EE. Molecular imaging and gene therapy. J Nucl Med. 2001;42:1368–1374
  5. Verel I, Visser GWM, Vosjan MJWD, Finn R, Boellaard R, van Dongen GAMS. High quality I-124-labelled monoclonal antibodies for use as PET scouting agents prior to I-131-radioimmunotherapy. Eur J Nucl Med Mol Imaging. 2004;31:1645–1652
  6. Green LA, Nguyen K, Berenji B, Iyer M, Bauer E, Barrio JR, et al. A tracer kinetic model for F-18-FHBG for quantitating herpes simplex virus type 1 thymidine kinase reporter gene expression in living animals using PET. J Nucl Med. 2004;45:1560–1570
  7. Tjuvajev JG, Avril N, Oku T, Sasajima T, Miyagawa T, Joshi R, et al. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res. 1998;58:4333–4341
  8. Alauddin MM, Conti PS. Synthesis and preliminary evaluation of 9-(4-[F-18]-fluoro-3-hydroxymethylbutyl)guanine ([F-18]FHBG): a new potential imaging agent for viral infection and gene therapy using PET. Nucl Med Biol. 1998;25:175–180
  9. Monclus M, Luxen A, Cool V, Damhaut P, Velu T, Goldman S. Development of a positron emission tomography radiopharmaceutical for imaging thymidine kinase gene expression: synthesis and in vitro evaluation of 9-{(3-[F-18]fluoro-1-hydroxy-2-propoxy)methyl}guanine. Bioorg Med Chem Lett. 1997;7:1879–1882
  10. Alauddin MM, Conti PS, Mazza SM, Hamzeh FM, Lever JR. Synthesis of 9-[(3-[F-18]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([F-18]-FHPG): a potential imaging agent of viral infection and gene therapy using PET. Nucl Med Biol. 1996;23:787–792
  11. Min J-J, Iyer M, Gambhir SS. Comparison of [F-18]FHBG and [C-14]FIAU for imaging of HSV1-tk reporter gene expression: adenoviral infection vs stable transfection. Eur J Nucl Med Mol Imaging. 2003;30:1547–1560
  12. Degrève B, Esnouf R, De Clercq E, Balzarini J. Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of alanine-167 to tyrosine. Mol Pharmacol. 2000;58:1326–1332
  13. Balzarini J, Bohman C, Walker RT, De Clercq E. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene transfected tumor cells. Mol Pharmacol. 1994;45:1253–1258
  14. Balzarini J, Morin KW, Knaus EE, Wiebe LI, De Clercq E. Novel (E)-5-(2-iodovinyl)-2′-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors. Gene Ther. 1995;2:317–322
  15. Yu C-S, Wu C-H, Chiang L-W, Wang R-T, Wang H-Y, Yeh C-H, et al. Synthesis of (E)-5-(2-radioiodovinyl)arabinosyl uridine analog for probing HSV-1 thymidine kinase gene. Chem Lett. 2005;34:1390–1391
  16. Yu C-S, Eisenbarth J, Runz A, Weber K, Zeisler S, Oberdorfer F. Syntheses of 5-(2-radiohaloethyl)- and 5-(2-radiohalovinyl)-2′-deoxyuridines. Novel types of radiotracer for monitoring cancer gene therapy with PET. J Label Compd Radiopharm. 2003;46:421–439
  17. Yu C-S, Oberdorfer F. Synthesis of a novel aldehyde: 4-O-methyl-5-formylmethyl-2′-deoxyuridine. Nucleosides Nucleotides Nucleic Acids. 2003;22:71–84
  18. Yu C-S, Oberdorfer F. Synthesis of 4-O-methyl-protected 5-(2-hydroxyethyl)-2′-deoxyuridine derivatives and their nucleophilic fluorination to 5-(2-fluoroethyl)-2′-deoxyuridine. Synthesis. 1999;2057–2064
  19. Yu C-S, Oberdorfer F. Synthesis of (E)-5-[2-(tri-n-butylstannyl)vinyl] substituted 2′-deoxyuridine derivatives for use in halogenation and radiohalogenation reactions. Synlett. 2000;86–88
  20. Vaidyanathan G, Zalutsky MR. Preparation of 5-[I-131]Iodo- and 5-[At-211]astato-1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)uracil by a halodestannylation reaction. Nucl Med Biol. 1998;25:487–496
  21. Toyohara J, Fujibayashi Y. Trends in nucleoside tracers for PET imaging of cell proliferation. Nucl Med Biol. 2003;30:681–685
  22. Ozaki H, Nakajima K, Tatsui K, Izumi C, Kuwahara M, Sawai H. Convenient synthesis of oligodeoxyribonucleotides bearing arabinofuranosyl pyrimidine derivatives and its duplex formation with complementary DNA. Bioorg Med Chem Lett. 2003;13:2441–2443
  23. Wnuk SF, Chowdhury SM, Garcia JPI, Robins MJ. Stereodefined synthesis of O3′-labeled uracil nucleosides. 3′-[O-17]-2′-azido-2′-deoxyuridine 5′-diphosphate as a probe for the mechanism of inactivation of ribonucleotide reductases. J Org Chem. 2002;67:1816–1819
  24. Schinazi RF, Chen MS, Prusoff WH. Anti-viral and anti-neoplastic activities of pyrimidine arabinosyl nucleosides and their 5′-amino derivatives. J Med Chem. 1979;22:1273–1277
  25. Hampton A, Nichol AW. Nucleotides. V. purine ribonucleoside 2′, 3′-cyclic carbonates. Preparation and use for the synthesis of 5′-monosubstituted nucleosides. Biochemistry. 1966;5:2076
  26. Pankiewicz KW, Watanabe KA. Nucleosides. 143. Synthesis of 5′-deoxy-5′-substituted-2,2′-anhydro-1-(beta-d-arabinofuranosyl)uracils — a new 2,5′-anhydronucleoside to 2,2′-anhydronucleoside transformation — studies directed toward the synthesis of 2′-deoxy-2′-substituted arabino nucleosides.4. Chem Pharm Bull. 1987;35:4494–4497
  27. Codington JF, Fecher R, Fox JJ. Pyrimidine nucleosides. vii. reactions of 2′,3 ′,5′-trimesyloxyuridine. J Am Chem Soc. 1960;82:2794–2803
  28. Robin MJ, Manfredini S, Wood SG, Wanklin RJ, Rennie BA, Sacks SL. Nucleic acid related compounds. 65. New syntheses of 1-(beta-d-arabinofuranosyl)-5(E)-(2-iodovinyl)uracil (IVaraU) from vinylsilane precursors — radioiodine uptake as a marker for thymidine kinase positive herpes viral-infections. J Med Chem. 1991;34:2275–2280
  29. Lin T-S, Gao YS. Synthesis and biological-activity of 5-(trifluoromethyl)- and 5-(pentafluoroethyl)pyrimidine nucleoside analogs. J Med Chem. 1983;26:598–601
  30. Brown DM, Todd A, Varadarajan S. Nucleotides. XXXVII The structure of uridylic acids a and b, and a synthesis of spongouridine (3-β-d-arabofuranosyluracil). J Chem Soc. 1966;2388
  31. Ono K, Ogasawara M, Ohashi A, Matsukage A, Takahashi T, Nakayama C, et al. Inhibitory effects of various 5-halogenated derivatives of 1-beta-d-arabinofuranosyluracil 5′-triphosphate on DNA polymerases from murine cells and oncornavirus substituent effects on inhibitory action. Biochemistry. 1982;21:1019–1024
  32. Saladino R, Crestini C, Francesca O, Nicoletti R. Ozonation of thionucleosides — a new chemical transformation of 4-thiouracil and 6-thioguanine nucleosides to cytosine and adenosine counterparts. Tetrahedron. 1995;51:3607–3616
  33. Asakura J, Robins MJ. Cerium(iv) catalyzed iodination at C5 of uracil nucleosides. Tetrahedron Lett. 1988;29:2855–2858
  34. Asakura J, Robins MJ. Cerium(iv)-mediated halogenation at C-5 of uracil derivatives. J Org Chem. 1990;55:4928–4933

PII: S0969-8051(05)00300-8

doi: 10.1016/j.nucmedbio.2005.12.005

Nuclear Medicine and Biology
Volume 33, Issue 3 , Pages 367-370 , April 2006

Article Tools

* Image Usage & Resolution